Ernexa Therapeutics Inc. (ERNA) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Ernexa Therapeutics Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.54x | -2.81x | -6.62x | -6.00x | -22.10x | 195.61x |
| P/B Ratio | 3.15x | 73.62x | 64.25x | 12.17x | 106.20x | 304.08x |
| P/S Ratio | 0.00x | 215.18x | 2109.97x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 83.5% | -247.1% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | -2693.1% | -31080.9% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | -7652.7% | -31864.7% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | -6206.0% | -29314.7% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 1.01x | 0.80x | 1.46x | 1.79x | 5.10x | 0.55x |
| Quick Ratio | 1.01x | 0.80x | 1.46x | 1.79x | 5.10x | 0.55x |
| Leverage | ||||||
| Debt/Equity | 0.20x | 0.40x | 18.74x | 0.34x | 0.11x | 0.38x |
YoY = year-over-year change. Source: FMP..